Acquisition - Hologic entered into an agreement to be acquired by Blackstone and TPG for $76 per share in cash plus a contingent value right of up to $3 per share, potentially reaching $79 per share[13] - The acquisition is expected to close in the first half of calendar year 2026[13] Financial Performance - Hologic's Q4'25 GAAP revenue was $1,049.5 million, a 6.2% increase compared to Q4'24[68] - Q4'25 Non-GAAP revenue was also $1,049.5 million, with organic revenue at $1,027.7 million and organic revenue excluding COVID at $998.6 million[69] - Hologic's GAAP diluted EPS for Q4'25 was $0.83, a 9.2% increase[68] - Non-GAAP diluted EPS for Q4'25 was $1.13, an 11.9% increase[69] - The company's net debt to adjusted EBITDA leverage ratio is 0.4x[59, 111] Segment Performance - Diagnostics revenue in Q4'25 was $454.1 million[70] - Breast Health revenue in Q4'25 was $393.7 million[70] - GYN Surgical revenue in Q4'25 was $172.5 million[70] - Skeletal Health revenue in Q4'25 was $29.2 million, a 128.1% increase[70]